Trial
NCT05006599
SNIFF - 3-Week Aptar CPS Device
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Wake Forest University Health Sciences
Collaborators
—
Condition
Mild Cognitive Impairment
Intervention
Insulin (Humulin® R U-100)
Why stopped
protocol being rewritten and submitted as new study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-07-28